Synthesis of oxa-bridged analogues of farnesyltransferase inhibitor RPR 115135

Two synthetic routes to new oxygen-bridged analogues of farnesyltransferase inhibitors are described that follow either a [3 + 2]/[4 + 2] or a [4 + 2]/[3 + 2] sequence of reactions. The first approach has been achieved by reacting the in situ generated phenylisobenzofuran (PIBF) 4 with pyrroline 5a and has led stereoselectively to racemic 18, which was transformed in a few steps into the target molecule 2. The second pathway relies on a key intermediate 6, obtained either by condensation of PIBF with methyl acrylate, followed by a deprotonation/selenation and an oxidation/elimination sequence, or by cycloaddition between PIBF and alpha-phenylselenoacrylate 11, followed by the same oxidation/elimination sequence. The reaction of 6 with amino dipole 7 gives diastereoselective access to pyrrolidine 25, a precursor of the second target 3, an epimer of 2.     

Bortrifluorid-katalysierte Umsetzungen von 3-Amino-2H-azirinen mit Aminosäure-estern und Aminen

Boron-Trifluoride-Catalyzed Reactions of 3-Amino-2H-azirines with Amino-acid Esters and Amines After activation by protonation or complexation with BF₃, 3-amino-2H-azirines 1 react with the amino group of α-amino-acid esters 3 to give 3,6-dihydro-5-aminopyrazin-2(1H)-ones 4 by ring enlargement (Scheme 2, Table 1). The configuration of 3 is retained in the products 4 . With unsymmetrically substituted 1 (R¹ ≠ R²), two diastereoisomers of 4 (cis and trans) are formed in a ratio of 1:1 to 2:1. With β-amino-acid esters 5 and 7 , only openchain α-amino-imidamides 6 and 8 , respectively, are formed, but none of the seven-membered heterocycle (Scheme 3). Primary amines also react with BF₃-complexed 1 to yield α-amino-imidamides of type 9 (Scheme 4, Table 2). Compound 9b is characterized chemically by its transformation into crystalline derivatives 10 and 12 with 4-nitrobenzoyl chloride and phenyl isothiocyanate, respectively (Scheme 5). The structure of 12 is established by X-ray crystallography. Mechanisms for the reaction of activated 1 with amino groups are proposed in Schemes 6 and 7.     

Porphyrins

The extended Hückel model is applied to porphyrin systems with metals Mn, Fe, Co, Ni, Cu, Zn and to the diprotic acid. A single method for choosing parameters is detailed. The model is used to discuss magnetic state, coupling of ring and metal, electronic transitions, and the effect of non-planarity.

---

Zusammenfassung Die erweiterte Hückel Theorie wird auf das Porphyrin-System mit den Metallen. Mn, Fe, Co, Ni, Cu und Zn sowie auf die zweifach protonierte Säure angewendet. Die Parameter werden dabei einheitlich gewählt. Anhand dieses Modells werden magnetische Eigenschaften, Kopplung zwischen Ring und Metall, Elektronenübergänge und der Einfluß der Abweichung von planarer Anordnung diskutiert.

---

Résumé Le modèle étendu de Hückel est appliqué aux complexes du porphyrine avec les métaux Mn, Fe, Co, Ni, Cu et Zn, et à l'acide diprotonique. On présente en détail une méthode unifiée pour obtenir les paramètres. L'état magnétique, le couplage cycle-métal, les transitions électroniques et l'effet de la non-planeïté sont discutés à l'aide de ce modèle.

---

---

National Institutes of Health Pre-Doctoral Fellow.     

N4-Benzoylspermidine from Oncinotis tenuiloba: Analytical differentiation of the three isomeric N-benzoylspermidines

During the examination of extracts from Oncinotis tenuiloba STAPF a new polyamine, N⁴-benzoylsperimidine ( 8 ), was isolated. For unambiguous structure elucidation, it was transformed into the diacetyl derivative 13 , and the three possible N-benzoyl-substituted isomers of spermidine 5, 8 , and 11 together with their peracetylated derivatives 12–14 , respectively, were synthesized and identified.     

ESR. Spectra and Structures of Radical Anions in the Dibenzo[a,e]cyclooctene Series

ESR. studies are reported for the radical anions of 5,6-didehydro- and 5,6,11,12-tetradehydro-dibenzo[a,e]cyclooctene (III and IV, resp.), in addition to that of dibenzo[a,e]cyclooctene (II) itself, the spectrum of which has been reexamined. Comparison of the proton and ¹³C coupling constants for II·?, III·? and IV·? indicates that the three radical anions do not differ greatly in their electronic and molecular structures. This statement implies that II·? should also be substantially planar, i.e., the tub-shaped eight-membered ring in II is expected to flatten on passing from the neutral molecule to its radical anion. Support for postulating such a change in geometry, analogous to that encountered with the parent cyclooctatetraene (I), is provided by INDO calculations.     

Li2H4I2O10, das erste Tetrahydrogendimesoperiodat

Li₂H₄I₂O₁₀, the First Tetrahydrogendimesoperiodate Li₂H₄I₂O₁₀ has been obtained as an intermediate during the dehydration of LiH₄IO₆ · H₂O to LiIO₄, for the first time. According to the results of an X-ray structure determination (monoclinic, P2₁/n, a = 533.98(4), b = 471.85(4), c = 1431.48(10) pm, β = 91.614(7)°, Z = 2, 726 diffractometer data, R = 0.056), Li₂H₄I₂O₁₀ contains the previously unknown tetrahydrogendimesoperiodate ion H₄I₂O₁₀^2?, consisting of two edge-shared IO₆ octahedra. They are connected with LiO₆ octahedra via common edges and vertices. The crystals are non-merohedrally twinned along (100).     

Eine neue Aminoazirin-Reaktion. Bildung von 3,6-Dihydropyrazin-2(1H)-onen

A New Aminoazirine Reaction. Formation of 3,6-Dihydropyrazin-2(1H)-ones The reaction of 3-(dimethylamino)-2H-azirines 1 and 2-(trifluoromethyl)-1,3-oxazol-5(2H)-ones 5 in MeCN or THF at 50–80° leads to 5-(dimethylamino)-3,6-dihydropyrazin-2(1H)-ones 6 (Scheme 3). Reaction mechanisms for the formation of 6 are discussed: either the oxazolones 5 react as CH-acidic heterocycles with 1 (Scheme 4), or the azirines 1 undergo a nucleophilic attack onto the carbonyl group of 5 (Scheme 6). The reaction via intermediate formation of N-(trifluoroacetyl)dipeptide amide 8 (Scheme 5) is excluded.     

Engineering novel bioactive mini-proteins from small size natural and de novo designed scaffolds

Mini-proteins, polypeptides containing less than 100 amino acids, such as (animal toxins, protease inhibitors, knottins, zinc fingers, etc.) represent successful structural solutions to the need to express a specific binding activity in different biological contexts. Artificial mini-proteins have also been designed de novo, representing simplified versions of natural folds and containing natural or artificial connectivities. Both systems have been used as structural scaffolds in the engineering of novel binding activities, according to three main approaches: i) incorporation of functional protein epitopes into structurally compatible regions of mini-protein scaffolds; ii) random mutagenesis and functional selection of particular structural regions of mini-protein scaffolds; iii) minimization of protein domains by the use of sequence randomization and functional selection, combined with structural information, in an iterative process. These newly engineered mini-proteins, with specific and high binding affinities within a small size and well-defined three-dimensional structure, represent novel tools in biology, biotechnology and medical sciences. In addition, some of them can also be directly used in therapy or present high potential to serve as drugs. In all cases, they represent precious structural intermediates useful to identify frameworks for peptidomimetic design or directly lead to new small organic structures, representing novel drug candidates. The engineering of novel functional mini-proteins has the potential to become a fundamental step towards the conversion of a protein functional epitope or a flexible peptide lead into a classical pharmaceutical.     

Iron-catalyzed homo-coupling of simple and functionalized arylmagnesium reagents

Iron-catalyzed homo-coupling of simple and functionalized arylmagnesium reagents is described. The reaction is highly chemoselective (CN, COOEt and NO(2) groups are tolerated). The procedure was used to perform intramolecular couplings. This cyclization reaction is the key step of the total synthesis of the N-methylcrinasiadine.